{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:25:40Z","timestamp":1790011540609,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD094634"],"award-info":[{"award-number":["R01HD094634"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD072663"],"award-info":[{"award-number":["R01HD072663"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Contributions from a diverse set of scientific disciplines will be needed to help individuals make fully informed decisions regarding contraceptive choices least likely to promote HIV susceptibility. This commentary recaps contrasting interpretations of results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial, a study that compared HIV risk in women using the progestin-only injectable contraceptive depot medroxyprogesterone acetate (DMPA) vs. two other contraceptive choices. It also summarizes results from basic and translational research that establish biological plausibility for earlier clinical studies that identified enhanced HIV susceptibility in women using DMPA.<\/jats:p>","DOI":"10.1093\/biolre\/ioaa078","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T05:04:05Z","timestamp":1592629445000},"page":"318-322","source":"Crossref","is-referenced-by-count":9,"title":["HIV, progestins, genital epithelial barrier function, and the burden of objectivity\u2020"],"prefix":"10.1093","volume":"103","author":[{"given":"Rodolfo D","family":"Vicetti Miguel","sequence":"first","affiliation":[{"name":"Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirk E","family":"Quispe Calla","sequence":"additional","affiliation":[{"name":"Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Cherpes","sequence":"additional","affiliation":[{"name":"Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"2020093001145048600_ref1","volume-title":"Global AIDS Update 2016","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2017"},{"key":"2020093001145048600_ref2","first-page":"68","article-title":"Increased use of injectable contraception in sub-Saharan Africa","volume":"16","author":"Ross","year":"2012","journal-title":"Afr J Reprod Health"},{"key":"2020093001145048600_ref3","volume-title":"Adding It Up: Costs and Benefits of Meeting the Contraceptive Needs of Adolescents","author":"Darroch","year":"2016"},{"key":"2020093001145048600_ref4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/padr.12051","article-title":"Contraceptive practice in sub-Saharan Africa","volume":"43","author":"Tsui","year":"2017","journal-title":"Popul Dev Rev"},{"key":"2020093001145048600_ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analyssis","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2020093001145048600_ref6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"key":"2020093001145048600_ref7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(12)70112-3","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission","volume":"12","author":"Shelton","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2020093001145048600_ref8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.olq.0000175374.98875.33","article-title":"Concerns regarding design, analysis, and interpretation of the Morrison study on hormonal contraceptive use and acquisition of cervical infections","volume":"32","author":"Warner","year":"2005","journal-title":"Sex Transm Dis"},{"key":"2020093001145048600_ref9","first-page":"303","article-title":"HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"27","author":"Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium","year":"2019","journal-title":"Lancet"},{"key":"2020093001145048600_ref10","volume-title":"Contraceptive Eligibility for Women at High Risk of HIV","author":"World Health Organization","year":"2019"},{"key":"2020093001145048600_ref11","doi-asserted-by":"crossref","first-page":"l5768","DOI":"10.1136\/bmj.l5768","article-title":"Depot contraception and HIV: an exercise in obfuscation","volume":"367","author":"Sathyamala","year":"2019","journal-title":"BMJ"},{"key":"2020093001145048600_ref12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","article-title":"Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk","volume":"27","author":"Butler","year":"2013","journal-title":"AIDS"},{"key":"2020093001145048600_ref13","first-page":"302","article-title":"Erratum for: HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial","volume":"27","author":"Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium","year":"2019","journal-title":"Lancet"},{"key":"2020093001145048600_ref14","doi-asserted-by":"crossref","first-page":"a018218","DOI":"10.1101\/cshperspect.a018218","article-title":"Epidermal barriers","volume":"4","author":"Natsuga","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2020093001145048600_ref15","doi-asserted-by":"crossref","first-page":"a029314","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2020093001145048600_ref16","doi-asserted-by":"crossref","first-page":"a015297","DOI":"10.1101\/cshperspect.a015297","article-title":"Desmosomes: regulators of cellular signaling and adhesion in epidermal health and disease","volume":"4","author":"Johnson","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2020093001145048600_ref17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.jid.5701015","article-title":"Desmosomes: new perspectives on a classic","volume":"127","author":"Green","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2020093001145048600_ref18","doi-asserted-by":"crossref","first-page":"a002543","DOI":"10.1101\/cshperspect.a002543","article-title":"The desmosome","volume":"1","author":"Delva","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2020093001145048600_ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053739","article-title":"Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion","volume":"8","author":"Hartlieb","year":"2013","journal-title":"PLoS One"},{"key":"2020093001145048600_ref20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-394311-8.00005-4","article-title":"Structure, function, and regulation of desmosomes","volume":"116","author":"Kowalczyk","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2020093001145048600_ref21","doi-asserted-by":"crossref","first-page":"a000125","DOI":"10.1101\/cshperspect.a000125","article-title":"Intercellular junction assembly, dynamics, and homeostasis","volume":"2","author":"Green","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2020093001145048600_ref22","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"key":"2020093001145048600_ref23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat Med"},{"key":"2020093001145048600_ref24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI0213236","article-title":"Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent","volume":"109","author":"Khanna","year":"2002","journal-title":"J Clin Invest"},{"key":"2020093001145048600_ref25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nm1096-1084","article-title":"Progesterone implants enhance SIV vaginal transmission and early virus load","volume":"2","author":"Marx","year":"1996","journal-title":"Nat Med"},{"key":"2020093001145048600_ref26","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/01.aids.0000131393.76221.cc","article-title":"Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect","volume":"18","author":"Smith","year":"2004","journal-title":"AIDS"},{"key":"2020093001145048600_ref27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/315776","article-title":"Estrogen protects against vaginal transmission of simian immunodeficiency virus","volume":"182","author":"Smith","year":"2000","journal-title":"J Infect Dis"},{"key":"2020093001145048600_ref28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1095\/biolreprod.111.094789","article-title":"Expression of structural proteins in human female and male genital epithelia and implications for sexually transmitted infections","volume":"86","author":"Dinh","year":"2012","journal-title":"Biol Reprod"},{"key":"2020093001145048600_ref29","doi-asserted-by":"crossref","first-page":"11388","DOI":"10.1128\/JVI.01377-13","article-title":"Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract","volume":"87","author":"Carias","year":"2013","journal-title":"J Virol"},{"key":"2020093001145048600_ref30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005885","article-title":"Increases in endogenous or exogenous progestins promote virus-target cell interactions within the non-human primate female reproductive tract","volume":"12","author":"Carias","year":"2016","journal-title":"PLoS Pathog"},{"key":"2020093001145048600_ref31","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/mi.2016.22","article-title":"Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection","volume":"9","author":"Quispe Calla","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2020093001145048600_ref32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2019.07.003","article-title":"Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion","volume":"100","author":"Quispe Calla","year":"2019","journal-title":"Contraception"},{"key":"2020093001145048600_ref33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4049\/immunohorizons.1900077","article-title":"Norethisterone enanthate increases mouse susceptibility to genital infection with herpes simplex virus type 2 and HIV type 1","volume":"4","author":"Quispe Calla","year":"2020","journal-title":"Immunohorizons"},{"key":"2020093001145048600_ref34","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25063","article-title":"Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice","volume":"21","author":"Quispe Calla","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"2020093001145048600_ref35","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/infdis\/jiy363","article-title":"Levonorgestrel and female genital tract immunity: time for a closer look","volume":"218","author":"Vicetti Miguel","year":"2018","journal-title":"J Infect Dis"},{"key":"2020093001145048600_ref36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/aji.12415","article-title":"Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract","volume":"74","author":"Deese","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"2020093001145048600_ref37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1933719114565035","article-title":"Progestin-containing contraceptives alter expression of host defense-related genes of the endometrium and cervix","volume":"22","author":"Goldfien","year":"2015","journal-title":"Reprod Sci"},{"key":"2020093001145048600_ref38","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/QAI.0000000000001174","article-title":"HIV and hormonal contraception: bench and bedside","volume":"74","author":"Quispe Calla","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020093001145048600_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17441692.2019.1634118","article-title":"In the name of science: ethical violations in the ECHO randomised trial","volume":"24","author":"Sathyamala","year":"2019","journal-title":"Glob Public Health"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioaa078\/33408988\/ioaa078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/103\/2\/318\/33804880\/ioaa078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/103\/2\/318\/33804880\/ioaa078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T05:16:03Z","timestamp":1601442963000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/103\/2\/318\/5837475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,5,15]]},"published-print":{"date-parts":[[2020,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioaa078","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,5,15]]}}}